The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8Martin Filipits, Peter Dubsky, Florian Fitzal et al.|Clinical Cancer Research|2021Cited by 3
Table S1 from The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8Martin Filipits, Peter Dubsky, Margaretha Rudas et al.|Unknown|2023Cited by 0